Ligand validation:5VB2

CPS: 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE

CPS is a Ligand Of Interest in 5VB2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VB2_CPS_A_1301	27%	53%	0.206	0.922	0.5	1.3	-	5	0	0	62%	0.619
5VB2_CPS_D_2301	24%	48%	0.252	0.95	0.51	1.49	-	9	0	0	62%	0.619
5VB2_CPS_B_2301	21%	47%	0.277	0.958	0.52	1.5	-	9	0	0	62%	0.619
5VB2_CPS_C_1301	17%	51%	0.281	0.93	0.5	1.37	-	8	1	0	62%	0.619
5VB2_CPS_D_2302	16%	51%	0.271	0.908	0.5	1.36	-	5	2	0	62%	0.619
5VB2_CPS_C_1302	13%	52%	0.318	0.935	0.53	1.3	-	5	0	0	62%	0.619
5VB2_CPS_B_2302	13%	49%	0.309	0.922	0.52	1.41	-	5	0	0	62%	0.619
5VB2_CPS_A_1302	11%	50%	0.333	0.918	0.49	1.41	-	8	0	0	62%	0.619
5KLB_CPS_B_1307	51%	0%	0.158	0.912	11.42	3.83	29	44	1	0	100%	0.9824
8DIV_CPS_A_1308	46%	75%	0.161	0.953	0.39	0.58	-	-	0	0	69%	0.6905
6MWG_CPS_B_2307	46%	2%	0.14	0.948	3.2	3.53	14	19	1	0	60%	0.5952
8DJ0_CPS_A_1307	43%	74%	0.159	0.937	0.41	0.6	-	-	0	0	69%	0.6905
6MWA_CPS_B_2306	37%	43%	0.179	0.939	0.69	1.49	-	9	0	0	67%	0.6667
5FEZ_CPS_A_402	96%	34%	0.057	0.967	1.46	1.15	7	5	0	0	100%	0.9571
3IIX_CPS_A_1701	95%	46%	0.058	0.963	1.33	0.76	1	-	0	0	100%	0.9571
5FF3_CPS_A_402	94%	30%	0.078	0.979	1.58	1.21	3	6	0	0	100%	0.9571
5FEW_CPS_A_402	94%	23%	0.074	0.973	2.03	1.14	7	7	0	0	100%	0.9571
5FES_CPS_A_402	94%	22%	0.069	0.967	1.93	1.35	9	10	0	0	100%	0.9571

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.